Literature DB >> 234679

Gram-negative bacillary endocarditis. Interpretation of the serum bactericial test.

C S Bryan, S R Marney, R H Alford, R E Bryant.   

Abstract

Although the serum bactericidal test is commonly used in the management of infective endocarditis, little has been written about its validity or limitations. We report three cases of gram-negative bacillary endocarditis (Pseudomonas aeruginosa, Vibrio fetus and Serratia marcescens) encountered in 1 year at a Veterans Administration hospital. Serum bactericidal titers were considered necessary to identify inadequate antibiotic regimens or to avoid unnecessary drug toxicity. The limitations of the test, particularly those pertaining to gram-negative infections, are reviewed. Misleading results during treatment with aminoglycoside antibiotics could be due to the tendency of serum to become alkaline on standing. A detailed study of the interaction of the complement-dependent bactericidal system of serum with eight antibiotics is presented. In the context of the serum bactericidal test, the interaction was additive or synergistic in 15 of 16 determinations, indicating the need to include a control study of serum sensitivity of the infecting microorganism in each case.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 234679     DOI: 10.1016/0002-9343(75)90571-9

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  11 in total

1.  Synergism and antagonism among antimicrobial drugs. A personal perspective.

Authors:  E Jawetz
Journal:  West J Med       Date:  1975-08

Review 2.  Serum bactericidal test.

Authors:  C W Stratton
Journal:  Clin Microbiol Rev       Date:  1988-01       Impact factor: 26.132

3.  Use and interpretation of Schlichter's test on Haemophilus influenzae: relation of in vitro to in vivo results for cefamandole.

Authors:  E Yourassowsky; M P van der Linden; E Schoutens
Journal:  J Clin Pathol       Date:  1979-09       Impact factor: 3.411

Review 4.  Value of the serum bactericidal test in management of patients with bacterial endocarditis.

Authors:  J W Mellors; D L Coleman; V T Andriole
Journal:  Eur J Clin Microbiol       Date:  1986-02       Impact factor: 3.267

5.  Isolation of an ampicillin-resistant, non-beta-lactamase-producing strain of Haemophilus influenzae.

Authors:  S M Markowitz
Journal:  Antimicrob Agents Chemother       Date:  1980-01       Impact factor: 5.191

6.  Cerebrospinal fluid penetration of amikacin.

Authors:  D J Briedis; H G Robson
Journal:  Antimicrob Agents Chemother       Date:  1978-06       Impact factor: 5.191

7.  Sulfamethoxazole-trimethoprim-polymyxin therapy of serious multiply drug-resistant Serratia infections.

Authors:  F E Thomas; J M Leonard; R H Alford
Journal:  Antimicrob Agents Chemother       Date:  1976-02       Impact factor: 5.191

8.  Antibiotic concentrations in serum, serum bactericidal activity, and results of therapy of streptococcal endocarditis in rabbits.

Authors:  J Carrizosa; D Kaye
Journal:  Antimicrob Agents Chemother       Date:  1977-10       Impact factor: 5.191

9.  Correlation of in vitro activities of cephalothin and ceftazidime with their efficacies in the treatment of Staphylococcus aureus endocarditis in rabbits.

Authors:  R L Baker; R J Fass
Journal:  Antimicrob Agents Chemother       Date:  1984-08       Impact factor: 5.191

10.  In vitro activity of gentamicin, amikacin and netilmicin alone and in combination with carbenicillin against Serratia marcescens.

Authors:  S M Pogwizd; S A Lerner
Journal:  Antimicrob Agents Chemother       Date:  1976-12       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.